ArticleNature medicine2022

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.

Andrew X Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.